Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist

Financials

Latest Financial Results

FY 2023

Fiscal Year Ended Dec 31, 2023

>$75M Total fourth quarter 2023 revenue of $75.9 million
>$315M Total full-year 2023 revenue of $315.7 million
>40% Total full-year 2023 gross margin of 40.1%

For complete information regarding our financials, see our periodic filings

View the Latest Financials

Balance Sheet

Includes Current Assets, Liabilities and Stockholder's Equity

View Balance Sheet

Income Statement

Includes Total Net Sales, Cost & Expenses and Earnings per share

View Income Statement

Cash Flow

Includes Net Income, Adjustments, and Cash flows from investing & financing activities

View Cash Flow